A pilot program to build the next generation of biotech and medical device entrepreneurs at the National Institutes of Health is looking for a few good biomedical researchers. A National Science Foundation initiative that equips scientists with business training to help them transition from academia to the business world has been expanded to biomedical researchers, according to an NIH statement. The goal is to accelerate the development and commercialization of drugs, devices and services.
The Innovation Corps at NIH, or I-Corps, will accept applications from SBIR and SBTT Phase 1 award recipients from the National Cancer Institute, the National Heart, Lung and Blood Institute, the National Institute of Neurological Disorders and Stroke, and the National Center for Advancing Translational Sciences. Candidates can submit applications starting July 7.
The 24 teams selected for I-Corps at NIH will receive training from I-Corps instructors with biomedical business experience who take a scientific method-based approach to customer discovery, according to the statement.
With the Rise of AI, What IP Disputes in Healthcare Are Likely to Emerge?
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
The nine-week boot camp will educate biomedical entrepreneurs on business matters such as how their companies can protect intellectual property and develop regulatory and reimbursement strategies.
Michael Weingarten, director of the NCI SBIR Development Center, said he and his colleagues reached out to NSF after seeing the difference I-Corps made for graduates. More than 300 three-person teams have completed the NSF I-Corps training, to date.
NIH will begin outreach to the small business research community next week with a June 25 program briefing at the BIO International Convention. For those who can’t make it to San Diego, a webinar is scheduled for July 2.
